POVIDONE

POVIDONE was reported 4273 times

POVIDONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INSTILLATION SITE WARMTH 1 0.1111
1 BULLOUS KERATOPATHY 1 0.0714
2 DRUG-DEVICE INTERACTION 6 0.0541
3 OPTIC DISC HYPERAEMIA 1 0.0400
4 OCULAR PROCEDURAL COMPLICATION 6 0.0309
5 CHORIORETINAL SCAR 2 0.0241
6 ANTI FACTOR X ACTIVITY INCREASED 1 0.0185
7 MYALGIA INTERCOSTAL 1 0.0167
8 CARDIAC RESYNCHRONISATION THERAPY 1 0.0141
9 AUTOPHONY 1 0.0133
10 OVERWORK 1 0.0128
11 IMMUNE-MEDIATED ENCEPHALOPATHY 1 0.0112
12 BINOCULAR EYE MOVEMENT DISORDER 3 0.0104
13 RETINAL PIGMENT EPITHELIAL TEAR 6 0.0086
14 BLEPHAROPLASTY 1 0.0082
15 ATROPHY OF GLOBE 1 0.0078
16 HISTIOCYTOSIS 1 0.0075
17 EYE ABSCESS 2 0.0066
18 RETINAL DEPIGMENTATION 2 0.0065
19 OPEN GLOBE INJURY 1 0.0061
20 POSTERIOR CAPSULE OPACIFICATION 2 0.0058
21 NIPPLE EXUDATE BLOODY 1 0.0053
22 GINGIVAL INFLAMMATION 1 0.0053
23 EYE ULCER 3 0.0052
24 DEAFNESS PERMANENT 1 0.0051
25 VITREAL CELLS 1 0.0050
26 VITRITIS 8 0.0043
27 ANTERIOR CHAMBER FLARE 1 0.0043
28 ONYCHOPHAGIA 1 0.0036
29 VOCAL CORD POLYP 1 0.0035
30 CELLULITIS ORBITAL 2 0.0034
31 PUNCTATE KERATITIS 3 0.0033
32 PARACENTESIS 2 0.0033
33 HEPATIC VEIN THROMBOSIS 1 0.0032
34 VENTRICULAR TACHYARRHYTHMIA 1 0.0031
35 PELVIC NEOPLASM 1 0.0029
36 VASCULAR INSUFFICIENCY 1 0.0026
37 VITREOUS OPACITIES 2 0.0024
38 ENDOCRINE OPHTHALMOPATHY 2 0.0023
39 REFLUX LARYNGITIS 1 0.0023
40 IRIDOCYCLITIS 7 0.0022
41 ALLERGY TO ARTHROPOD STING 1 0.0022
42 ANASTOMOTIC ULCER 1 0.0022
43 PANCREATITIS HAEMORRHAGIC 1 0.0022
44 KERATIC PRECIPITATES 1 0.0021
45 PRODUCT AFTER TASTE 2 0.0021
46 VITREOUS DISORDER 1 0.0021
47 DUODENAL STENOSIS 1 0.0021
48 CORNEAL SCAR 1 0.0020
49 DIABETIC RETINAL OEDEMA 1 0.0020
50 INSTILLATION SITE ERYTHEMA 1 0.0019
51 INFUSION SITE CELLULITIS 1 0.0019
52 CORNEAL EROSION 1 0.0019
53 STOMA SITE IRRITATION 1 0.0018
54 INTERTRIGO 1 0.0018
55 TOXIC ANTERIOR SEGMENT SYNDROME 2 0.0018
56 ECZEMA EYELIDS 1 0.0018
57 SPINAL EPIDURAL HAEMATOMA 1 0.0017
58 SINOATRIAL BLOCK 1 0.0017
59 EYELID SKIN DRYNESS 2 0.0016
60 INFUSION SITE WARMTH 2 0.0016
61 SITTING DISABILITY 1 0.0016
62 OCULAR HYPERTENSION 3 0.0015
63 BLOOD IMMUNOGLOBULIN A DECREASED 1 0.0015
64 CONCOMITANT DISEASE PROGRESSION 3 0.0015
65 ENDOPHTHALMITIS 9 0.0015
66 CORNEAL OPACITY 2 0.0015
67 MULTIPLE USE OF SINGLE-USE PRODUCT 8 0.0014
68 SUSPICIOUSNESS 1 0.0014
69 FEBRILE BONE MARROW APLASIA 6 0.0014
70 ANTERIOR CHAMBER CELL 1 0.0014
71 CONGENITAL HYDRONEPHROSIS 1 0.0014
72 BITE 1 0.0014
73 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 1 0.0013
74 CORNEAL TRANSPLANT 1 0.0013
75 PROCEDURAL NAUSEA 1 0.0012
76 BASAL GANGLIA HAEMORRHAGE 1 0.0012
77 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 1 0.0012
78 MYOCARDIAL FIBROSIS 1 0.0012
79 CHOROIDAL NEOVASCULARISATION 1 0.0012
80 FOLLICULAR LYMPHOMA 1 0.0011
81 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 1 0.0011
82 ULCERATIVE KERATITIS 3 0.0011
83 CORONAVIRUS INFECTION 7 0.0011
84 ANIMAL SCRATCH 1 0.0010
85 MUSCLE RUPTURE 4 0.0010
86 INFUSION SITE DISCOMFORT 1 0.0010
87 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
88 ALLERGY TO ANIMAL 1 0.0009
89 PNEUMONIA STREPTOCOCCAL 1 0.0009
90 FACIAL SPASM 1 0.0009
91 HALO VISION 1 0.0009
92 INSTILLATION SITE IRRITATION 1 0.0008
93 REFLUX GASTRITIS 1 0.0008
94 RETINAL TEAR 2 0.0008
95 ALLERGY TO CHEMICALS 1 0.0008
96 HYPERAESTHESIA TEETH 1 0.0008
97 SUBCUTANEOUS HAEMATOMA 1 0.0008
98 TRANSITIONAL CELL CARCINOMA 1 0.0008
99 HERPES OPHTHALMIC 1 0.0008
100 EXTRADURAL HAEMATOMA 1 0.0008
101 EYE INFLAMMATION 7 0.0007
102 INFUSION SITE RASH 1 0.0007
103 DISCHARGE 1 0.0007
104 ABNORMAL SENSATION IN EYE 3 0.0007
105 PANCREATIC ENZYMES INCREASED 1 0.0007
106 CONJUNCTIVITIS ALLERGIC 1 0.0007
107 INFUSION SITE INDURATION 1 0.0007
108 STEROID DIABETES 1 0.0007
109 SUPERINFECTION 1 0.0007
110 MOUTH INJURY 1 0.0007
111 IMMUNE THROMBOCYTOPENIA 3 0.0007
112 ORAL MUCOSAL ERUPTION 1 0.0007
113 SKIN REACTION 9 0.0006
114 SWELLING OF EYELID 4 0.0006
115 INFUSION SITE PRURITUS 2 0.0006
116 COSTOCHONDRITIS 1 0.0006
117 CARDIOVASCULAR INSUFFICIENCY 1 0.0006
118 INFUSION SITE HAEMORRHAGE 2 0.0006
119 ARTHROPOD STING 1 0.0006
120 LACK OF INJECTION SITE ROTATION 1 0.0006
121 JUGULAR VEIN THROMBOSIS 1 0.0006
122 METAMORPHOPSIA 1 0.0005
123 OTOTOXICITY 1 0.0005
124 STOMA SITE ERYTHEMA 1 0.0005
125 BLOOD IRON INCREASED 1 0.0005
126 CYSTOID MACULAR OEDEMA 1 0.0005
127 RETINAL OEDEMA 1 0.0005
128 VISUAL ACUITY REDUCED 17 0.0005
129 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
130 OSTEOLYSIS 1 0.0005
131 ATRIAL THROMBOSIS 1 0.0005
132 INFUSION SITE SWELLING 3 0.0005
133 DEVICE CONNECTION ISSUE 1 0.0005
134 NEUROGENIC BLADDER 1 0.0005
135 EAR SWELLING 1 0.0005
136 HORDEOLUM 2 0.0005
137 VITREOUS DETACHMENT 1 0.0005
138 REACTION TO DRUG EXCIPIENTS 1 0.0005
139 ELECTROCARDIOGRAM T WAVE INVERSION 1 0.0005
140 RETROPERITONEAL HAEMATOMA 1 0.0005
141 CORNEAL OEDEMA 1 0.0004
142 REACTION TO EXCIPIENT 1 0.0004
143 NEPHROGENIC ANAEMIA 2 0.0004
144 ROSACEA 2 0.0004
145 ORAL SURGERY 1 0.0004
146 MYOPIA 1 0.0004
147 VISUAL FIELD DEFECT 3 0.0004
148 WRONG DOSE 1 0.0004
149 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
150 EYE IRRITATION 23 0.0004
151 EYELID IRRITATION 1 0.0004
152 VASODILATATION 1 0.0004
153 CATHETER SITE PAIN 1 0.0004
154 RETINAL DISORDER 1 0.0004
155 AGRANULOCYTOSIS 7 0.0004
156 ANIMAL BITE 1 0.0004
157 BLOOD DISORDER 3 0.0004
158 WHITE BLOOD CELL DISORDER 1 0.0004
159 FOOD POISONING 2 0.0004
160 PRODUCT DELIVERY MECHANISM ISSUE 2 0.0004
161 ERYTHEMA OF EYELID 2 0.0004
162 UVEITIS 5 0.0004
163 STOMA SITE DISCHARGE 1 0.0004
164 TYPE IV HYPERSENSITIVITY REACTION 1 0.0004
165 INFUSION SITE ERYTHEMA 3 0.0004
166 EYE PAIN 20 0.0004
167 DUODENAL ULCER HAEMORRHAGE 1 0.0003
168 EYELID MARGIN CRUSTING 1 0.0003
169 URINE OUTPUT DECREASED 3 0.0003
170 SYRINGE ISSUE 6 0.0003
171 CRANIOCEREBRAL INJURY 1 0.0003
172 PROSTATE CANCER STAGE II 1 0.0003
173 EYELIDS PRURITUS 1 0.0003
174 PHOTOPSIA 2 0.0003
175 FAECAL CALPROTECTIN INCREASED 1 0.0003
176 ORTHOPNOEA 1 0.0003
177 EXPOSURE TO TOXIC AGENT 1 0.0003
178 POSTURE ABNORMAL 1 0.0003
179 VITREOUS FLOATERS 3 0.0003
180 INJECTION SITE INFECTION 1 0.0003
181 PROSTATE CANCER METASTATIC 1 0.0003
182 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
183 GRANULOMA 1 0.0003
184 POLYMENORRHOEA 1 0.0003
185 NERVOUS SYSTEM DISORDER 9 0.0003
186 RETINAL HAEMORRHAGE 2 0.0003
187 CONJUNCTIVAL HYPERAEMIA 1 0.0003
188 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
189 BONE LESION 1 0.0003
190 BLOOD PHOSPHORUS DECREASED 1 0.0003
191 OCULAR DISCOMFORT 3 0.0003
192 CHRONIC SINUSITIS 1 0.0003
193 PHOTOPHOBIA 5 0.0003
194 EYE INFECTION 3 0.0003
195 FACE INJURY 1 0.0003
196 DERMATITIS CONTACT 3 0.0003
197 INSURANCE ISSUE 4 0.0003
198 ATRIOVENTRICULAR BLOCK 2 0.0003
199 SPINAL CORD COMPRESSION 1 0.0003
200 WOUND SECRETION 1 0.0003
201 MULTIPLE ALLERGIES 2 0.0003
202 TRIGEMINAL NEURALGIA 1 0.0002
203 ENURESIS 1 0.0002
204 SPINAL FUSION SURGERY 1 0.0002
205 DRY EYE 12 0.0002
206 ACCIDENTAL EXPOSURE 1 0.0002
207 HALLUCINATIONS, MIXED 1 0.0002
208 LIP OEDEMA 1 0.0002
209 SHOULDER OPERATION 1 0.0002
210 INFUSION SITE PAIN 3 0.0002
211 MELANOCYTIC NAEVUS 1 0.0002
212 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2 0.0002
213 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
214 RETINAL DETACHMENT 2 0.0002
215 SYNOVIAL CYST 1 0.0002
216 PRODUCT DISTRIBUTION ISSUE 2 0.0002
217 EYE SWELLING 8 0.0002
218 FLANK PAIN 2 0.0002
219 SKIN ABRASION 1 0.0002
220 CHOLESTASIS 4 0.0002
221 RASH VESICULAR 1 0.0002
222 RENAL CELL CARCINOMA 1 0.0002
223 KNEE OPERATION 2 0.0002
224 NASAL POLYPS 1 0.0002
225 HEPARIN-INDUCED THROMBOCYTOPENIA 1 0.0002
226 HEPATIC ENZYME ABNORMAL 1 0.0002
227 DERMATITIS EXFOLIATIVE 1 0.0002
228 DRUG TOLERANCE 1 0.0002
229 DYSPHORIA 1 0.0002
230 HYPOTHERMIA 2 0.0002
231 PATHOLOGICAL FRACTURE 1 0.0002
232 PHLEBITIS 1 0.0002
233 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
234 FAILURE TO THRIVE 1 0.0002
235 EYE DISCHARGE 2 0.0002
236 PARTIAL SEIZURES 1 0.0002
237 PRODUCT USE COMPLAINT 3 0.0002
238 OCULAR HYPERAEMIA 9 0.0002
239 INJECTION SITE DISCHARGE 1 0.0002
240 SKIN INFECTION 2 0.0002
241 PERIORBITAL SWELLING 1 0.0002
242 CHOLECYSTITIS ACUTE 1 0.0002
243 MOUTH SWELLING 1 0.0002
244 EYELID OEDEMA 2 0.0002
245 SKIN WARM 1 0.0002
246 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
247 COLD SWEAT 3 0.0002
248 CATARACT OPERATION 1 0.0002
249 PLEURISY 1 0.0002
250 VISION BLURRED 23 0.0002
251 LACRIMATION INCREASED 5 0.0002
252 END STAGE RENAL DISEASE 3 0.0002
253 PROTEINURIA 3 0.0002
254 FOREIGN BODY SENSATION IN EYES 1 0.0002
255 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
256 GLAUCOMA 3 0.0002
257 INCOHERENT 1 0.0002
258 DRUG SPECIFIC ANTIBODY PRESENT 1 0.0002
259 ORAL HERPES 3 0.0002
260 TENDON DISORDER 1 0.0002
261 ORAL CANDIDIASIS 2 0.0002
262 CATARACT 9 0.0002
263 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
264 TERMINAL STATE 1 0.0001
265 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
266 BREAST MASS 1 0.0001
267 EYE PRURITUS 5 0.0001
268 HAIR GROWTH ABNORMAL 1 0.0001
269 HYPERTRANSAMINASAEMIA 1 0.0001
270 BLINDNESS UNILATERAL 2 0.0001
271 DUODENAL ULCER 1 0.0001
272 SEASONAL ALLERGY 2 0.0001
273 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
274 FAECES SOFT 1 0.0001
275 VISUAL IMPAIRMENT 17 0.0001
276 BLINDNESS TRANSIENT 1 0.0001
277 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
278 ARTHROPOD BITE 1 0.0001
279 HYPOAESTHESIA ORAL 2 0.0001
280 TROPONIN INCREASED 1 0.0001
281 LIPASE INCREASED 1 0.0001
282 PHARYNGEAL OEDEMA 2 0.0001
283 APHTHOUS ULCER 1 0.0001
284 HYPOALBUMINAEMIA 1 0.0001
285 GASTROINTESTINAL INFLAMMATION 1 0.0001
286 BRAIN FOG 2 0.0001
287 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
288 FURUNCLE 1 0.0001
289 NASAL DISCOMFORT 1 0.0001
290 PNEUMOTHORAX 2 0.0001
291 RENAL CYST 1 0.0001
292 DRUG INTOLERANCE 12 0.0001
293 MUSCLE DISORDER 1 0.0001
294 PRESYNCOPE 3 0.0001
295 POST PROCEDURAL INFECTION 1 0.0001
296 POLYURIA 1 0.0001
297 VITAMIN D DECREASED 1 0.0001
298 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
299 PRODUCT CONTAINER ISSUE 1 0.0001
300 PSEUDOMONAS INFECTION 1 0.0001
301 ANAPHYLACTIC SHOCK 3 0.0001
302 BLOOD MAGNESIUM DECREASED 1 0.0001
303 MUSCLE STRAIN 1 0.0001
304 RESPIRATORY TRACT INFECTION 3 0.0001
305 FACIAL PAIN 1 0.0001
306 HAEMARTHROSIS 1 0.0001
307 GASTROINTESTINAL INFECTION 1 0.0001
308 CONJUNCTIVITIS 2 0.0001
309 ERYTHEMA MULTIFORME 1 0.0001
310 SQUAMOUS CELL CARCINOMA 1 0.0001
311 HYPOCALCAEMIA 2 0.0001
312 HYPERCHOLESTEROLAEMIA 1 0.0001
313 PHARYNGEAL SWELLING 1 0.0001
314 LIGAMENT SPRAIN 1 0.0001
315 INABILITY TO AFFORD MEDICATION 1 0.0001
316 CARDIAC FAILURE 8 0.0001
317 TOXIC SKIN ERUPTION 1 0.0001
318 DRY THROAT 1 0.0001
319 SUBARACHNOID HAEMORRHAGE 1 0.0001
320 POOR VENOUS ACCESS 1 0.0001
321 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
322 FULL BLOOD COUNT ABNORMAL 1 0.0001
323 SUDDEN DEATH 1 0.0001
324 BREAST PAIN 1 0.0001
325 BODY HEIGHT DECREASED 1 0.0001
326 HYPERTENSIVE CRISIS 1 0.0001
327 GAIT INABILITY 3 0.0001
328 NECK PAIN 5 0.0001
329 ORAL PAIN 2 0.0001
330 THERAPY NON-RESPONDER 4 0.0001
331 MADAROSIS 1 0.0001
332 VASCULITIS 1 0.0001
333 BACTERAEMIA 1 0.0001
334 MACULAR DEGENERATION 1 0.0001
335 ACCIDENT 1 0.0001
336 MUSCLE RIGIDITY 1 0.0001
337 LOCALISED INFECTION 2 0.0001
338 ADRENAL INSUFFICIENCY 1 0.0001
339 DRUG INTERACTION 13 0.0001
340 CARDIOMEGALY 1 0.0001
341 HYPERCALCAEMIA 1 0.0001
342 GENERALISED OEDEMA 1 0.0001
343 PNEUMONIA ASPIRATION 2 0.0001
344 INJECTION SITE DISCOLOURATION 1 0.0001
345 CHRONIC KIDNEY DISEASE 6 0.0001
346 ACUTE KIDNEY INJURY 12 0.0001
347 INTRAOCULAR PRESSURE INCREASED 1 0.0001
348 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
349 HAEMATOMA 2 0.0001
350 PLATELET COUNT INCREASED 1 0.0001
351 BEDRIDDEN 1 0.0001
352 GASTRITIS 2 0.0001
353 SARS-COV-2 TEST POSITIVE 1 0.0001
354 QUALITY OF LIFE DECREASED 1 0.0001
355 OEDEMA 4 0.0001
356 PERIPHERAL COLDNESS 1 0.0001
357 ANAPHYLACTIC REACTION 4 0.0001
358 DIVERTICULITIS 2 0.0001
359 ORAL DISCOMFORT 1 0.0001
360 CARPAL TUNNEL SYNDROME 1 0.0001
361 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
362 HEPATOCELLULAR INJURY 1 0.0001
363 CARDIOGENIC SHOCK 1 0.0001
364 IMPAIRED QUALITY OF LIFE 1 0.0001
365 PARAESTHESIA ORAL 1 0.0001
366 HYPERTHYROIDISM 1 0.0001
367 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
368 RENAL INJURY 2 0.0001
369 PULMONARY MASS 1 0.0001
370 HYPOAESTHESIA 10 0.0001
371 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
372 DRUG DISPENSING ERROR 1 0.0001
373 DEVICE ADHESION ISSUE 1 0.0001
374 HYPOKALAEMIA 3 0.0001
375 CEREBROVASCULAR ACCIDENT 11 0.0001
376 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
377 THYROID DISORDER 1 0.0001
378 MUSCULOSKELETAL CHEST PAIN 1 0.0001
379 DELUSION 1 0.0001
380 EJECTION FRACTION DECREASED 1 0.0001
381 THERAPY PARTIAL RESPONDER 1 0.0001
382 BASAL CELL CARCINOMA 1 0.0001
383 RASH ERYTHEMATOUS 3 0.0001
384 SENSORY DISTURBANCE 1 0.0001
385 HIP FRACTURE 2 0.0001
386 INTERSTITIAL LUNG DISEASE 3 0.0001
387 RHINORRHOEA 4 0.0001
388 BLOOD CREATININE INCREASED 4 0.0001
389 METASTASES TO BONE 1 0.0001
390 PHOTOSENSITIVITY REACTION 1 0.0001
391 DRUG LEVEL INCREASED 1 0.0001
392 PERICARDITIS 1 0.0001
393 CANDIDA INFECTION 1 0.0001
394 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
395 HEMIPARESIS 1 0.0001
396 PARANOIA 1 0.0001
397 HYPERKALAEMIA 2 0.0001
398 BRADYCARDIA 3 0.0001
399 HEAD DISCOMFORT 1 0.0001
400 THIRST 1 0.0001
401 GOUT 1 0.0001
402 RESTLESSNESS 2 0.0001
403 HAEMATOCHEZIA 3 0.0001
404 HEPATIC STEATOSIS 1 0.0001
405 BACTERIAL INFECTION 1 0.0001
406 BLISTER 3 0.0001
407 HYPONATRAEMIA 3 0.0001
408 INTESTINAL OBSTRUCTION 2 0.0001
409 BLOOD SODIUM DECREASED 1 0.0001
410 COLITIS 2 0.0001
411 FOOT FRACTURE 1 0.0001
412 INCREASED APPETITE 1 0.0001
413 PULMONARY FIBROSIS 1 0.0001
414 POST PROCEDURAL COMPLICATION 1 0.0001
415 EAR PAIN 1 0.0001
416 MENORRHAGIA 1 0.0001
417 BLOOD PRESSURE ABNORMAL 1 0.0001
418 INTENTIONAL SELF-INJURY 1 0.0000
419 FEEDING DISORDER 1 0.0000
420 PLEURAL EFFUSION 3 0.0000
421 BLINDNESS 2 0.0000
422 INJECTION SITE WARMTH 1 0.0000
423 CARDIO-RESPIRATORY ARREST 2 0.0000
424 DERMATITIS 1 0.0000
425 HALLUCINATION, VISUAL 1 0.0000
426 DEEP VEIN THROMBOSIS 3 0.0000
427 SWELLING FACE 3 0.0000
428 APPLICATION SITE PAIN 1 0.0000
429 ANGIOEDEMA 2 0.0000
430 STEVENS-JOHNSON SYNDROME 1 0.0000
431 RASH MACULO-PAPULAR 1 0.0000
432 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
433 SNEEZING 1 0.0000
434 THROAT IRRITATION 2 0.0000
435 PANCREATITIS ACUTE 1 0.0000
436 HEART RATE IRREGULAR 1 0.0000
437 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
438 COGNITIVE DISORDER 2 0.0000
439 PRODUCT USE ISSUE 8 0.0000
440 COMA 2 0.0000
441 MIGRAINE 4 0.0000
442 PRODUCTIVE COUGH 2 0.0000
443 INFECTION 6 0.0000
444 AGITATION 3 0.0000
445 LUNG DISORDER 2 0.0000
446 SYNCOPE 4 0.0000
447 HALLUCINATION 3 0.0000
448 ABDOMINAL PAIN LOWER 1 0.0000
449 PRODUCT COMPLAINT 1 0.0000
450 HYPOPHAGIA 1 0.0000
451 DRUG RESISTANCE 1 0.0000
452 ERYTHEMA 8 0.0000
453 UNRESPONSIVE TO STIMULI 1 0.0000
454 EXPOSURE VIA SKIN CONTACT 1 0.0000
455 DEAFNESS 1 0.0000
456 JOINT STIFFNESS 1 0.0000
457 ANHEDONIA 1 0.0000
458 DERMATITIS ATOPIC 2 0.0000
459 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
460 PROSTATE CANCER 3 0.0000
461 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
462 FREQUENT BOWEL MOVEMENTS 1 0.0000
463 BLOOD BILIRUBIN INCREASED 1 0.0000
464 PALLOR 1 0.0000
465 HEADACHE 23 0.0000
466 NAUSEA 29 0.0000
467 SKIN LESION 1 0.0000
468 RESPIRATORY DISTRESS 1 0.0000
469 PROCEDURAL PAIN 1 0.0000
470 PAIN IN JAW 1 0.0000
471 FLATULENCE 2 0.0000
472 HERPES ZOSTER 2 0.0000
473 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
474 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
475 DISEASE PROGRESSION 4 0.0000
476 URINARY INCONTINENCE 1 0.0000
477 GASTROINTESTINAL DISORDER 3 0.0000
478 RESPIRATORY DISORDER 1 0.0000
479 BLOOD POTASSIUM DECREASED 1 0.0000
480 APHASIA 1 0.0000
481 THERAPEUTIC RESPONSE DECREASED 2 0.0000
482 DISCOMFORT 2 0.0000
483 INJECTION SITE RASH 1 0.0000
484 GYNAECOMASTIA 1 0.0000
485 CONSTIPATION 7 0.0000
486 COUGH 9 0.0000
487 DRUG-INDUCED LIVER INJURY 1 0.0000
488 METABOLIC ACIDOSIS 1 0.0000
489 CONFUSIONAL STATE 5 0.0000
490 ATRIAL FIBRILLATION 3 0.0000
491 CHOLELITHIASIS 1 0.0000
492 DYSPEPSIA 3 0.0000
493 IMPAIRED HEALING 1 0.0000
494 EYE DISORDER 1 0.0000
495 STAPHYLOCOCCAL INFECTION 1 0.0000
496 INFUSION RELATED REACTION 2 0.0000
497 BACK PAIN 7 0.0000
498 VIRAL INFECTION 1 0.0000
499 FALL 10 0.0000
500 LIP SWELLING 1 0.0000
501 SKIN DISORDER 1 0.0000
502 URINARY RETENTION 1 0.0000
503 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
504 URINARY TRACT INFECTION 5 0.0000
505 CHEST DISCOMFORT 3 0.0000
506 SINUSITIS 3 0.0000
507 ILLNESS 3 0.0000
508 NIGHTMARE 1 0.0000
509 DELIRIUM 1 0.0000
510 ABDOMINAL DISTENSION 3 0.0000
511 WEIGHT DECREASED 8 0.0000
512 BURNING SENSATION 2 0.0000
513 COVID-19 5 0.0000
514 HEART RATE DECREASED 1 0.0000
515 DEVICE MALFUNCTION 2 0.0000
516 SLEEP DISORDER 2 0.0000
517 LYMPHADENOPATHY 1 0.0000
518 PRODUCT USE IN UNAPPROVED INDICATION 7 0.0000
519 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
520 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
521 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
522 C-REACTIVE PROTEIN INCREASED 1 0.0000
523 PANIC ATTACK 1 0.0000
524 ACCIDENTAL OVERDOSE 1 0.0000
525 DYSURIA 1 0.0000
526 CHEST PAIN 5 0.0000
527 DYSGEUSIA 2 0.0000
528 EPISTAXIS 2 0.0000
529 BLOOD PRESSURE INCREASED 4 0.0000
530 INJECTION SITE SWELLING 2 0.0000
531 PALPITATIONS 3 0.0000
532 ARTHRITIS 2 0.0000
533 PSORIATIC ARTHROPATHY 1 0.0000
534 DYSKINESIA 1 0.0000
535 ARTHRALGIA 10 0.0000
536 ABDOMINAL DISCOMFORT 4 0.0000
537 PAIN IN EXTREMITY 7 0.0000
538 OSTEOARTHRITIS 1 0.0000
539 MYALGIA 4 0.0000
540 RECTAL HAEMORRHAGE 1 0.0000
541 BALANCE DISORDER 2 0.0000
542 DEVICE DISLOCATION 1 0.0000
543 SEPTIC SHOCK 1 0.0000
544 MENTAL DISORDER 1 0.0000
545 RASH 10 0.0000
546 INTENTIONAL PRODUCT MISUSE 2 0.0000
547 PAIN 14 0.0000
548 DRUG INEFFECTIVE 30 0.0000
549 RENAL FAILURE 3 0.0000
550 DRY SKIN 3 0.0000
551 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
552 MUSCLE SPASMS 4 0.0000
553 TINNITUS 1 0.0000
554 SKIN DISCOLOURATION 1 0.0000
555 NASOPHARYNGITIS 4 0.0000
556 OFF LABEL USE 19 0.0000
557 OROPHARYNGEAL PAIN 2 0.0000
558 DECREASED APPETITE 5 0.0000
559 SWELLING 2 0.0000
560 DYSPHAGIA 2 0.0000
561 NEUROPATHY PERIPHERAL 2 0.0000
562 MULTIPLE SCLEROSIS 1 0.0000
563 GAIT DISTURBANCE 4 0.0000
564 HYPOGLYCAEMIA 1 0.0000
565 PRODUCT DOSE OMISSION ISSUE 6 0.0000
566 PYREXIA 7 0.0000
567 DIARRHOEA 13 0.0000
568 CELLULITIS 1 0.0000
569 FLUSHING 2 0.0000
570 FLUID RETENTION 1 0.0000
571 PERIPHERAL SWELLING 3 0.0000
572 INFLAMMATION 1 0.0000
573 NERVOUSNESS 1 0.0000
574 HAEMORRHAGE 2 0.0000
575 SPEECH DISORDER 1 0.0000
576 PANCREATITIS 1 0.0000
577 DEPRESSED MOOD 1 0.0000
578 INSOMNIA 5 0.0000
579 ASTHENIA 7 0.0000
580 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
581 TREATMENT NONCOMPLIANCE 1 0.0000
582 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
583 TREMOR 3 0.0000
584 PANCYTOPENIA 1 0.0000
585 TOXICITY TO VARIOUS AGENTS 3 0.0000
586 PRODUCT SUBSTITUTION ISSUE 1 0.0000
587 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
588 SURGERY 1 0.0000
589 VOMITING 8 0.0000
590 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
591 IRRITABILITY 1 0.0000
592 JOINT SWELLING 2 0.0000
593 EMOTIONAL DISTRESS 2 0.0000
594 STOMATITIS 1 0.0000
595 CONDITION AGGRAVATED 5 0.0000
596 VERTIGO 1 0.0000
597 FEELING HOT 1 0.0000
598 INJECTION SITE PAIN 5 0.0000
599 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
600 HYPERSENSITIVITY 3 0.0000
601 ANAEMIA 3 0.0000
602 PRURITUS 6 0.0000
603 HYPERHIDROSIS 2 0.0000
604 AMNESIA 1 0.0000
605 DEVICE DIFFICULT TO USE 1 0.0000
606 BLOOD PRESSURE DECREASED 1 0.0000
607 DEHYDRATION 2 0.0000
608 HYPOTENSION 3 0.0000
609 HEPATIC ENZYME INCREASED 1 0.0000
610 ABDOMINAL PAIN UPPER 3 0.0000
611 INJURY 1 0.0000
612 HYPERTENSION 3 0.0000
613 DYSPNOEA 8 0.0000
614 FATIGUE 11 0.0000
615 DIZZINESS 7 0.0000
616 THERAPY INTERRUPTED 1 0.0000
617 SKIN BURNING SENSATION 1 0.0000
618 RESPIRATORY FAILURE 1 0.0000
619 MALAISE 6 0.0000
620 BRONCHITIS 1 0.0000
621 WEIGHT INCREASED 3 0.0000
622 ACNE 1 0.0000
623 INJECTION SITE HAEMORRHAGE 1 0.0000
624 THROMBOSIS 1 0.0000
625 DRY MOUTH 1 0.0000
626 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
627 INFLUENZA LIKE ILLNESS 1 0.0000
628 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
629 DEATH 10 0.0000
630 MUSCULOSKELETAL STIFFNESS 1 0.0000
631 TACHYCARDIA 1 0.0000
632 DEVICE ISSUE 1 0.0000
633 ADVERSE EVENT 1 0.0000
634 BREAST CANCER 1 0.0000
635 CARDIAC DISORDER 1 0.0000
636 BLOOD GLUCOSE INCREASED 2 0.0000
637 ANXIETY 3 0.0000
638 CONTUSION 1 0.0000
639 ALOPECIA 2 0.0000
640 SOMNOLENCE 2 0.0000
641 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
642 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
643 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
644 PLATELET COUNT DECREASED 1 0.0000
645 INFLUENZA 1 0.0000
646 RHEUMATOID ARTHRITIS 1 0.0000
647 MUSCULAR WEAKNESS 1 0.0000
648 INCORRECT DOSE ADMINISTERED 2 0.0000
649 SEIZURE 1 0.0000
650 CHILLS 1 0.0000
651 FEELING ABNORMAL 2 0.0000
652 INJECTION SITE ERYTHEMA 1 0.0000
653 LOSS OF CONSCIOUSNESS 1 0.0000
654 PSORIASIS 1 0.0000
655 PRODUCT QUALITY ISSUE 1 0.0000
656 NEUTROPENIA 1 0.0000
657 MEMORY IMPAIRMENT 1 0.0000
658 HOSPITALISATION 1 0.0000
659 PNEUMONIA 2 0.0000
660 DRUG DOSE OMISSION 1 0.0000
661 URTICARIA 1 0.0000
662 NO ADVERSE EVENT 1 0.0000
663 OVERDOSE 1 0.0000
664 ABDOMINAL PAIN 1 0.0000